FindTrial
Sign In

Expanded Access to Velmanase Alfa

Status
AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT04959240
Enrollment
Unknown
Registered
2021-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alpha-Mannosidosis

Brief summary

Individual patient expanded access requests may be considered for patients who have no other treatment options.

Detailed description

Expanded access may provide access for treatment prior to approval by the local regulatory agency.

Interventions

DRUGVelmanase Alfa

Sponsors

Chiesi Farmaceutici S.p.A.
Lead SponsorINDUSTRY

Eligibility

Inclusion criteria

\-

Exclusion criteria

\-

Contacts

Primary ContactExpanded Access
GRD.EAP@chiesi.com(888) 661-9260
Backup ContactClinical Trials
clinicaltrials_info@chiesi.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026